Abbott Is Getting Tested [Seeking Alpha]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Seeking Alpha
Ethan Miller/Getty Images NewsAbbott Laboratories (ABTEarnings performanceAbbott recently reported earnings for the prior quarter, and the results were good, but not terribly well received. At least some of that has to do with uncertainty in the forward guidance, which is largely due to uncertainty on the continuing rate of use of Covid-19 tests. Abbott's BinaxNOW antigen test is the most sold Covid-19 self test.Last quarter, Abbott had $11.5 billion in global revenue, up over 7% from the same quarter in 2020. Full year 2021 sales came in at $43.1 billion in worldwide sales, and ABT earned $5.21 in adjusted diluted EPS.Abbott provided full-year guidance for 2022's adjusted diluted EPS from continuing operations of at least $4.70, which appears to be a problem. The market was likely anticipating higher guidance. This estimate includes a forecast for $2.5 billion in Covid-19 testing-related sales, but that is probably a low estimate.It appears that the company is only providing guidance
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- DexCom, Inc. (NASDAQ: DXCM) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- DexCom (DXCM) to Report Q1 Earnings: What's in the Cards? [Yahoo! Finance]Yahoo! Finance
- Epitel Receives FDA 510(k) Clearance for Two New Technologies: REMI Remote EEG Monitoring System for Ambulatory Use and REMI Vigilenz AI For Event Detection [Yahoo! Finance]Yahoo! Finance
- Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 2/8/24 - Beat
DXCM
Sec Filings
- 4/23/24 - Form 144
- 4/22/24 - Form ARS
- 4/22/24 - Form DEF
- DXCM's page on the SEC website